Viking Therapeutics (VKTX) – Corporate News
-
Viking Therapeutics (VKTX) Announces Results from Phase 1 Clinical Trial of Oral Tablet Formulation of VK2735
-
Viking Therapeutics (VKTX) Announces Pricing of $550 Mln Public Offering of Common Stock
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to VKTX Stock Lookup